Understanding supplements.
How do I evaluate what you're actually buying — in the aisle built on a diagnosis that doesn't exist?
The adrenal aisle is the estate's purest myth-market: its flagship category ('adrenal support' glandulars) was built for a condition ('adrenal fatigue') that no endocrine society recognizes — unregulated tissue concentrates sold to the tired, with variable content, no trial evidence, and the theoretical risk of containing active hormones that suppress the very axis they claim to support. The honest shelf is narrow: an adaptogen with real cortisol data and disclosed edges, the adrenal's concentrated vitamin at honest doses, and the calming mineral — plus the behavioral stack that outranks all three. Evaluation here is a single question: is this product treating a physiology or a folklore?
Ashwagandha Capsules
Standardized extract — the trial material
Vitamin C
Honest doses — the gap-filler tier
Magnesium Glycinate
Elemental-counted, tolerated form
'Adrenal Support' Glandulars
The myth's product line — retired
Standardized Root Extracts (KSM-66, Sensoril) ✅
The clinical-trial materials — root-only (KSM-66) or root-with-leaf (Sensoril), standardized to withanolide content. The standardization IS the product: dosing and effects are meaningless without it. 300–600 mg daily is the trial range; our thyroid-disorders page's product is the same molecule family with the same disclosed edge.
'Whole Root' Powders & Unstandardized Blends
The bulk-herb tier: withanolide content unknown and variable — the dose without the standardization is a guess. The 'ashwagandha' in stress-complex blends is usually this tier: the label borrows the trials the material can't match (the estate's standing borrowed-evidence lesson).
Choosing the Right Form & Dose
Label literacy in the adrenal aisle has four specific jobs:
- The standardization check: ashwagandha with a named extract (KSM-66, Sensoril) and withanolide standardization — or it isn't the trial material (the whole-root tier is a guess in a capsule).
- The C dose-honesty check: RDA 75–90 mg; produce-first; 1000 mg as gap-filler — and the saturation curve means divided doses absorb more total than one bolus.
- The magnesium math: elemental mg counted toward the 350 mg ceiling; glycinate the form; evening the timing for the axis population.
- The myth-check (the aisle's main job): glandulars, cocktails, and 'cortisol balance' blends — the category built for the diagnosis that doesn't exist, retired by the physiology of Chapters 1–2. If the label says 'supports exhausted adrenals,' the label is quoting the myth this page just retired.
- The standing rule: third-party verification (USP, NSF, ConsumerLab) — especially in the category where unregulated tissue concentrates are sold; the glandular shelf is the verification argument in its purest form.
Red Flags to Watch For
The adrenal market sells to the chronically tired with a myth for a catalog. Be highly cautious of products that:
- Diagnose you from the label — 'for exhausted adrenals,' 'adrenal fatigue formula,' 'cortisol balance blend': the product line of a non-diagnosis, sold to symptoms that deserve a workup (thyroid, anemia, sleep apnea, depression — the real causes of most fatigue).
- Contain desiccated adrenal tissue (glandulars) — unregulated concentrates with variable content and the theoretical active-hormone risk: the steroid-pill logic without the prescription's control.
- Sell DHEA as anti-aging — a hormone on null trials: the decline-correlation fallacy priced as a fountain.
- Market salivary 'adrenal profiles' as diagnosis — rhythm data without clinical interpretation: numbers that generate worry, not answers.
- Lack third-party verification — in the category where tissue concentrates and hormone-adjacent products are the norm, the unverified label is the unassessed risk.